Ledger.Open graph →

SEC Form D · filed November 19, 2020

AavantiBio, Inc

Offering

$106.9M

Sold

$41.8M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

GAINESVILLE, FL

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Benjamin R. Lund · GAINESVILLE, FLExec · Director Philip R. Johnson, M.D · GAINESVILLE, FLExec · Director Bo Cumbo · GAINESVILLE, FLExec · Director Barry J. Byrne, M.D., Ph.D · GAINESVILLE, FLExec · Director Douglas J. Swirsky · Gaithersburg, MDExec · Director Jake R. Simson · GAINESVILLE, FLExec · Director Manuela J. Corti, Pt, Ph.D · GAINESVILLE, FLExec · Director Ellen J. Hukkelhoven, Ph.D · GAINESVILLE, FLExec · Director Bo Cumbo · GAINESVILLE, FLExec · Director Barry J. Byrne, M.D., Ph.D · GAINESVILLE, FLExec · Director Douglas J. Swirsky · Madison, WIExec · Director Jake R. Simson · GAINESVILLE, FLExec · Director Benjamin R. Lund · GAINESVILLE, FLExec · Director Philip R. Johnson, M.D · GAINESVILLE, FLExec · Director Manuela J. Corti, Pt, Ph.D · GAINESVILLE, FLExec · Director Ellen J. Hukkelhoven, Ph.D · GAINESVILLE, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗